BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27584563)

  • 1. I
    Madias JE
    Int J Cardiol; 2016 Nov; 223():877-878. PubMed ID: 27584563
    [No Abstract]   [Full Text] [Related]  

  • 2. Ivabradine in patients with inappropriate sinus tachycardia.
    Zellerhoff S; Hinterseer M; Felix Krull B; Schulze-Bahr E; Fabritz L; Breithardt G; Kirchhof P; Kääb S
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):483-6. PubMed ID: 20859616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO; Celik S; Ehlermann P; Frankenstein L; Zehelein J; Koch A; Katus HA; Dengler TJ
    Transplantation; 2007 Oct; 84(8):988-96. PubMed ID: 17989604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
    Ptaszynski P; Kaczmarek K; Ruta J; Klingenheben T; Wranicz JK
    Europace; 2013 Jan; 15(1):116-21. PubMed ID: 22772053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.
    Nuding S; Ebelt H; Hoke RS; Krummenerl A; Wienke A; Müller-Werdan U; Werdan K
    Clin Res Cardiol; 2011 Oct; 100(10):915-23. PubMed ID: 21638157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective effects of the Ιf current inhibition by ivabradine during cardiac dysfunction.
    Su JB
    Curr Pharm Biotechnol; 2014; 14(14):1213-9. PubMed ID: 24831809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivabradine as an alternative therapeutic trial in the therapy of inappropriate sinus tachycardia: a case report.
    Schulze V; Steiner S; Hennersdorf M; Strauer BE
    Cardiology; 2008; 110(3):206-8. PubMed ID: 18057886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivabradine for Uncontrolled Sinus Tachycardia in Thyrotoxic Cardiomyopathy - Case Report.
    Frenkel A; Bichovsky Y; Arotsker N; Besser L; Joshua BZ; Fraenkel M; Zahger D; Klein M
    Endocr Metab Immune Disord Drug Targets; 2023; 23(7):992-995. PubMed ID: 36518043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pediatric case of cardiomyopathy induced by inappropriate sinus tachycardia: efficacy of ivabradine.
    Romeo E; Grimaldi N; Sarubbi B; D'Alto M; Santarpia G; Scognamiglio G; Russo MG; Calabrò R
    Pediatr Cardiol; 2011 Aug; 32(6):842-5. PubMed ID: 21479666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of inappropriate sinus tachycardia with ivabradine.
    Annamaria M; Lupo PP; Foresti S; De Ambroggi G; de Ruvo E; Sciarra L; Cappato R; Calo L
    J Interv Card Electrophysiol; 2016 Jun; 46(1):47-53. PubMed ID: 26467151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias.
    Mert KU; Mert GÖ; Morrad B; Tahmazov S; Mutlu F; Çavuşoglu Y
    Kardiol Pol; 2017; 75(8):786-793. PubMed ID: 28541596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate sinus tachycardia - successful treatment with ivabradine.
    Celebi OO; Canbay A; Celebi S; Aydogdu S; Diker E
    Kardiol Pol; 2010 Aug; 68(8):935-7. PubMed ID: 20730728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
    Ptaszynski P; Kaczmarek K; Ruta J; Klingenheben T; Cygankiewicz I; Wranicz JK
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):338-44. PubMed ID: 23426376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven?
    Yusuf S; Camm AJ
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):89-105. PubMed ID: 12808482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stable angina pectoris. Effective symptom control and cardioprotection with ivabradine].
    MMW Fortschr Med; 2010 May; 152(21):102-3. PubMed ID: 20608138
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of inappropriate sinus tachycardia with ivabradine in a renal transplant recipient.
    Kumar Goyal V; Godara S; Chandra Sadasukhi T; Lal Gupta H
    Drug Discov Ther; 2014 Jun; 8(3):132-3. PubMed ID: 25031045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate sinus tachycardia: focus on ivabradine.
    Abed HS; Fulcher JR; Kilborn MJ; Keech AC
    Intern Med J; 2016 Aug; 46(8):875-83. PubMed ID: 27059112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart rate lowering by inhibition of the pacemaker current: a new therapeutic perspective in cardiovascular disease.
    Dilaveris P; Giannopoulos G; Synetos A; Gatzoulis K; Stefanadis C
    Cardiovasc Hematol Agents Med Chem; 2006 Oct; 4(4):313-8. PubMed ID: 17073608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.
    Cappato R; Castelvecchio S; Ricci C; Bianco E; Vitali-Serdoz L; Gnecchi-Ruscone T; Pittalis M; De Ambroggi L; Baruscotti M; Gaeta M; Furlanello F; Di Francesco D; Lupo PP
    J Am Coll Cardiol; 2012 Oct; 60(15):1323-9. PubMed ID: 22981555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.